Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Appointed director
GALECTIN THERAPEUTICS INC (GALT) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2019 8-K/A Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT NO. 1 TO FORM 8-K",
"First Amendment to Common Stock Purchase Warrant, by and between Richard E. Uihlein and the Company",
"First Amendment to Line of Credit Agreement, by and between Richard E. Uihlein and the Company"
12/19/2017 8-K/A Submission of Matters to a Vote of Security Holders
Docs: "8-K/A"
08/18/2017 8-K/A Quarterly results
03/30/2009 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/15/2008 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Placement Agent Agreement dated February 12, 2008, by and between Pro-Pharmaceuticals, Inc. and Maxim Group, LLC"
09/27/2007 8-K/A Appointed a new director
Docs: "Employment Agreement, made effective as of October 1, 2007, between Pro- Pharmaceuticals, Inc. and Theodore D. Zucconi, Ph.D"
09/18/2002 8-K/A Other events
03/08/2002 8-K/A Changes in registrant's certifying accountant, Financial statements and exhibits
Docs: "Securities and Exchange Commission 450 5th Street, N.W. Washington, D.C. 20549 Gentlemen:",
"Letter from Scillia Dowling & Natarelli LLC to the Commission, concerning change in certifying accountant * Also filed as Exhibit 16 with Registrant's Current Report on Form 8-K as filed with the Commission on February 25, 2002; renumbered and refiled herewith"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy